Tag: Silk Road Medical

Silk Road Medical announces FDA approval of expanded indications for the...

Silk Road Medical recently announced that the US Food and Drug Administration (FDA) approved expanded indications for the company's Enroute stent to include patients...
tcar restenotic carotid lesions

Cost-effectiveness of TCAR versus carotid endarterectomy addressed in new study

A cost-effectiveness model based on peer-reviewed sources suggests that, although five-year costs for transcarotid artery revascularisation (TCAR; Silk Road Medical) were higher than those for...
tcar restenotic carotid lesions

TCAR may be associated with favourable outcomes for treatment of restenotic...

Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...

First ever analysis of TCAR in standard surgical risk patients demonstrates...

Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularisation...

Study finds hospital availability of TCAR associated with an improvement in...

Silk Road Medical has announced positive results from a comparative-effectiveness study have been published in JAMA Network Open. The study found the availability of TCAR...